Observation of clinical effect of Moxifloxacin in treatment of elderly patients with acute pneumonia
Weifeng Liu
Abstract
Weifeng Liu
Abstract
Objective:To observe the clinical effect of Moxifloxacin in treatment of elderly patients with acute pneumonia.Methods:66 patients were randomly divided into 2 groups,33 patients were treated with Moxifloxacin(treatment group) and 33 patients were treated with Levofloxacin(control group).Results:The effective rate,bacterial clearing rate and occurrence of the adverse reaction for treatment group were 90.91%,93.94%,9.09% respectively and for control group were 78.79%,81.82%,12.12% respectively,the effective rate,bacterial clearing rate of two groups were compared,the differences were statistically significant(P0.05),while the adverse reaction of two groups were compared,the difference was not significant(P0.05).Conclusion:Moxifloxacin is a safe and effective medicine for treating elderly patients with acute pneumonia.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective:To observe the clinical effect of Moxifloxacin in treatment of elderly patients with acute pneumonia.Methods:66 patients were randomly divided into 2 groups,33 patients were treated with Moxifloxacin(treatment group) and 33 patients were treated with Levofloxacin(control group).Results:The effective rate,bacterial clearing rate and occurrence of the adverse reaction for treatment group were 90.91%,93.94%,9.09% respectively and for control group were 78.79%,81.82%,12.12% respectively,the effective rate,bacterial clearing rate of two groups were compared,the differences were statistically significant(P0.05),while the adverse reaction of two groups were compared,the difference was not significant(P0.05).Conclusion:Moxifloxacin is a safe and effective medicine for treating elderly patients with acute pneumonia.
Key concepts: Medicine, Moxifloxacin, Levofloxacin, Pneumonia, Internal medicine, Adverse effect, Antibiotics, Biology